Visionize LLC — Department of Health and Human Services SBIR Phase I: N

Visionize LLC — SBIR Phase I award from Department of Health and Human Services.

Amount
$220,062
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
N
Solicitation
PA16-302
NAICS
Place of performance
CA
Period
2017-09-30 → 2018-03-31

Description

Project Summary Visionize has developed a sophisticated wearable state of the art low vision aid by reprogramming a readily available low cost off the shelf Virtual Reality system The device operates in three main modes The patient views the real world with adjustable magnification power and area within the overall scene The patient also has access to the full complement of digital media ranging from digital news and email to digital streaming media like Netflix and you tube The clinician has diagnostic capability via remote access to patient display and responses The device is built from the Samsung Galaxy S phone one of the most advanced on the market inserted into a Samsung Gear VR headset On the phone display the low vision user sees an enhanced version of the visual world tuned to specific visual deficit The goal of this project is to refine the function of the device to a level where it can be successfully deployed to a population of test patients at the Johns Hopkins low vision clinic Then the device will be further refined and enhanced through feedback from the patient population The end goal is to develop a low vision aid with superior performance that can be distributed to a large low vision population worldwide at an affordable price PROJECT NARRATIVE The project focuses upon the clinical testing design development and implementation of a function universal low vision device that will allow the patient read view TV see at theater sports events recognize grandchildren find supermarket items allow access to all digital media content including news and streaming video and perform remote clinical testing via internet The device is built on a Virtual Reality platform reprogrammed for low vision making it widely accessible inexpensive and continuously upgradeable to the latest technology Design will be followed by full clinical evaluation with take home devices